Octozi
New York, United States · $150K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Business Model
- B2B
- Website
- octozi.com
- Total Funding
- $150K
- Last Round
- $150K Venture RoundJun 2025
- Rounds
- 2
About
AI platform automating clinical development workflows for biopharma sponsors, including data cleaning, review, and early safety signal detection.
Summary
Octozi is a Biotech company based in New York, United States. It has raised $150K in total across 2 rounds, most recently a $150K Venture Round round in Jun 2025. Investors include Debiopharm Innovation.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company